Viewing StudyNCT00003382

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003382
Status: TERMINATED
Last Update Posted: 2013-06-10
First Post: 1999-11-01
Brief Title: Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer
Sponsor: Gynecologic Oncology Group
Organization: GOG Foundation
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Primary Peritoneal Cavity Cancer
Fallopian Tube Cancer
Ovarian Cancer
Keywords:
Name View
primary peritoneal cavity cancer View
stage I ovarian epithelial cancer View
stage II ovarian epithelial cancer View
stage III ovarian epithelial cancer View
stage IV ovarian epithelial cancer View
recurrent ovarian epithelial cancer View
fallopian tube cancer View